Catapres Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

catapres

clinect nz pty limited - clonidine hydrochloride 150 µg/ml - solution for injection - 150 mcg/ml - active: clonidine hydrochloride 150 µg/ml excipient: hydrochloric acid sodium chloride water for injection - parenteral catapres is indicated for the treatment of hypertensive crises, slow parenteral administration is especially suitable due to the rapid onset of action.

Catapres Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

catapres

clinect nz pty limited - clonidine hydrochloride 150ug - tablet - 150 mcg - active: clonidine hydrochloride 150ug excipient: calcium hydrogen phosphate colloidal silicon dioxide lactose monohydrate maize starch povidone stearic acid

Catapres-TTS Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

catapres-tts

carsl consulting - clonidine 2.5mg - transdermal patch - 2.5 mg - active: clonidine 2.5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

Catapres-TTS Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

catapres-tts

carsl consulting - clonidine 5mg - transdermal patch - 5 mg - active: clonidine 5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

Catapres-TTS Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

catapres-tts

carsl consulting - clonidine 7.5mg - transdermal patch - 7.5 mg - active: clonidine 7.5mg excipient: calcium stearate - catapres-tts is indicated for the treatment of mild to moderate hypertension. it can be used as monotherapy or concomitantly with other antihypertensive agents if required to enhance hypotensive effect.

Clonidine (Teva) Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

clonidine (teva)

teva pharma (new zealand) limited - clonidine hydrochloride 25ug - tablet - 25 mcg - active: clonidine hydrochloride 25ug excipient: lactose monohydrate magnesium stearate maize starch microcrystalline cellulose pregelatinised maize starch purified talc sodium starch glycolate - the prophylactic management of migraine or recurrent vascular headaches in adult patients. the management of vasomotor conditions commonly associated with the menopause and characterised by flushing.

Dixarit Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

dixarit

boehringer ingelheim (nz) limited - clonidine hydrochloride 25ug - tablet - 25 mcg - active: clonidine hydrochloride 25ug excipient: acacia amylodextrin calcium hydrogen phosphate dihydrate carnauba wax colloidal silicon dioxide indigo carmine   lactose monohydrate macrogol 6000 magnesium stearate maize starch methyl hydroxybenzoate povidone   propyl hydroxybenzoate purified talc sucrose titanium dioxide white beeswax

Survanta Nowa Zelandia - angielski - Medsafe (Medicines Safety Authority)

survanta

abbvie limited - bovine lung lipids 25 mg/ml (total phospholipids); colfosceril palmitate 11 mg/ml - 15.5 mg/ml (disaturated phosphatidylcholine); palmitic acid 1.4 mg/ml - 3.5 mg/ml (free fatty acid); tripalmitin 0.5 mg/ml - 1.75 mg/ml (triglycerides) - intratracheal suspension - 25 mg/ml - active: bovine lung lipids 25 mg/ml (total phospholipids) colfosceril palmitate 11 mg/ml - 15.5 mg/ml (disaturated phosphatidylcholine) palmitic acid 1.4 mg/ml - 3.5 mg/ml (free fatty acid) tripalmitin 0.5 mg/ml - 1.75 mg/ml (triglycerides) excipient: sodium chloride water for injection - survanta is indicated for prevention and treatment ("rescue") of respiratory distress syndrome (rds) (hyaline membrane disease) in premature infants. survanta significantly reduces the incidence of rds, mortality due to rds and air leak complications.

XYLAPAN 20 MG/ML SOLUTION FOR INJECTION Irlandia - angielski - HPRA (Health Products Regulatory Authority)

xylapan 20 mg/ml solution for injection

vetoquinol uk limited - xylazin hydrochloride - solution for injection - 20 mg/ml - xylazine - bovine, canine, equine - food, feline - neurological preparations